Patents by Inventor Yoshiko Akamatsu

Yoshiko Akamatsu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CTLA4 proteins and their uses
    Patent number: 8642557
    Abstract: The present disclosure relates to CTLA4 proteins and uses of such proteins, for example to treat diseases associated with the dysregulation of immune responses.
    Type: Grant
    Filed: March 11, 2011
    Date of Patent: February 4, 2014
    Assignee: Abbvie Biotherapeutics Inc.
    Inventors: Yoshiko Akamatsu, Veronica Juan, Robert B. Dubridge
  • CTLA4 PROTEINS AND THEIR USES
    Publication number: 20130330338
    Abstract: The present disclosure relates to CTLA4 proteins and uses of such proteins, for example to treat diseases associated with the dysregulation of immune responses.
    Type: Application
    Filed: August 15, 2013
    Publication date: December 12, 2013
    Applicant: AbbVie Biotherapeutics Inc.
    Inventors: Yoshiko AKAMATSU, Veronica Juan, Robert B. Dubridge
  • ANTI-TNF-a ANTIBODIES AND THEIR USES
    Publication number: 20120135005
    Abstract: The present disclosure relates to antibodies directed to the tumor necrosis factor alpha (“TNF-?”) and uses of such antibodies, for example, to treat diseases associated with the activity and/or overproduction of TNF-?.
    Type: Application
    Filed: April 16, 2010
    Publication date: May 31, 2012
    Inventors: Fiona A. Harding, Yoshiko Akamatsu, Robert B. Dubridge, David B. Powers
  • Mammalian cell-based immunoglobulin display libraries
    Patent number: 8163546
    Abstract: Disclosed are mammalian cell surface display vectors for isolating and/or characterizing immunoglobulins and various uses thereof.
    Type: Grant
    Filed: March 26, 2010
    Date of Patent: April 24, 2012
    Assignee: Abbott Biotherapeutics Corp.
    Inventors: Yoshiko Akamatsu, Tsuneaki Asai, Naoya Tsurushita
  • CTLA4 PROTEINS AND THEIR USES
    Publication number: 20110305712
    Abstract: The present disclosure relates to CTLA4 proteins and uses of such proteins, for example to treat diseases associated with the dysregulation of immune responses.
    Type: Application
    Filed: March 11, 2011
    Publication date: December 15, 2011
    Inventors: Yoshiko Akamatsu, Veronica Juan
  • ANTI-HER2 ANTIBODIES AND THEIR USES
    Publication number: 20110177095
    Abstract: The present disclosure relates to antibodies directed to HER2 and uses of such antibodies, for example to treat diseases associated with the activity and/or overproduction of HER2.
    Type: Application
    Filed: December 15, 2010
    Publication date: July 21, 2011
    Applicant: Abbott Biotherapeutics Corporation
    Inventors: Fiona A. Harding, Yoshiko Akamatsu, Robert B. Dubridge, David B. Powers
  • ANTI-EGFR ANTIBODIES AND THEIR USES
    Publication number: 20110117110
    Abstract: The present invention relates to antibodies directed to EGFR and uses of such antibodies, for example, to treat diseases associated with the activity and/or overproduction of EGFR.
    Type: Application
    Filed: October 28, 2010
    Publication date: May 19, 2011
    Applicant: Facet Biotech Corporation
    Inventors: Yoshiko AKAMATSU, Robert B. Dubridge, David B. Powers
  • MAMMALIAN CELL-BASED IMMUNOGLOBULIN DISPLAY LIBRARIES
    Publication number: 20110008883
    Abstract: Disclosed are mammalian cell surface display vectors for isolating and/or characterizing immunoglobulins and various uses thereof.
    Type: Application
    Filed: March 26, 2010
    Publication date: January 13, 2011
    Applicants: FACET BIOTECH CORPORATION, PDL BIOPHARMA, INC.
    Inventors: YOSHIKO AKAMATSU, TSUNEAKI ASAI, NAOYA TSURUSHITA
  • ANTI-VEGF ANTIBODIES AND THEIR USES
    Publication number: 20100322931
    Abstract: The present disclosure relates to antibodies directed to vascular endothelial growth factor (“VEGF”) and uses of such antibodies, for example to treat diseases associated with the activity and/or overproduction of VEGF.
    Type: Application
    Filed: June 17, 2010
    Publication date: December 23, 2010
    Inventors: Fiona A. Harding, Yoshiko Akamatsu, Robert B. DuBridge, David B. Powers
  • ANTI-TNF-ALPHA ANTIBODIES AND THEIR USES
    Publication number: 20100266613
    Abstract: The present invention relates to antibodies directed to the tumor necrosis factor alpha (“TNF-?”) and uses of such antibodies, for example to treat diseases associated with the activity and/or overproduction of TNF-?.
    Type: Application
    Filed: April 16, 2010
    Publication date: October 21, 2010
    Inventors: Fiona A. Harding, Yoshiko Akamatsu, Robert B. Dubridge, David B. Powers
  • Tethered vectors for cell surface immunoglobulin display
    Patent number: 7732195
    Abstract: Disclosed are mammalian cell surface display vectors for isolating and/or characterizing immunoglobulins and various uses thereof.
    Type: Grant
    Filed: November 1, 2007
    Date of Patent: June 8, 2010
    Assignee: Facet Biotech Corporation
    Inventors: Yoshiko Akamatsu, Tsuneaki Asai, Naoya Tsurushita
  • MAMMALIAN CELL-BASED IMMUNOGLOBULIN DISPLAY LIBRARIES
    Publication number: 20090111126
    Abstract: Disclosed are mammalian cell surface display vectors for isolating and/or characterizing immunoglobulins and various uses thereof.
    Type: Application
    Filed: November 1, 2007
    Publication date: April 30, 2009
    Applicant: PDL BIOPHARMA, INC.
    Inventors: Yoshiko Akamatsu, Tsuneaki Asai, Naoya Tsurushita
  • Rubber Composition and Sealing Material for Plasma Treatment Device
    Publication number: 20080153986
    Abstract: A rubber composition includes (a) a cross linkable fluoro elastomer, (b) a reactive fluorine-containing compound (excluding the cross linkable fluoro elastomer (a)) having a divalent perfluoropolyether structure or divalent perfluoroalkylene structure and containing, in the terminal or a side chain thereof, two or more of alkenyl groups capable of conducting an addition reaction at least with a hydroxyl group in the following organosilicon compound (c), and (c) a reactive organosilicon compound having two or more of hydroxyl groups in the molecule thereof and being capable of conducting an addition reaction with an alkenyl group in the above compound (b), in such amounts wherein the total amount of (b) and (c) is 1 to 10 parts by weight relative to 100 parts by weight of said rubber (a), and further includes a vulcanizing agent and optionally a crosslinking agent; and a sealing agent for a plasma treatment device, which is produced by subjecting said composition to a primary vulcanization and forming, and the
    Type: Application
    Filed: December 19, 2005
    Publication date: June 26, 2008
    Applicant: Nippon Valqua Industries, Ltd.
    Inventors: Ichinosuke Maeda, Takanori Tsutsui, Yoshiko Akamatsu